ing and targeted radiotherapy, particularly positron emission tomography (PET) and radioantibody-targeted therapy in oncology. He is a fellow of both the American College of Nuclear Physicians and the American College of Radiology. He is currently director of the American Board of Nuclear Medicine. He is the author and coauthor of more than 500 scholarly publications and has been awarded numerous honors including the Wylie medal of the U.S. Food and Drug Administration, the Academy of Molecular Imaging Distinguished Scientist Award (2007), the Wagner Lecture Medal of the Society of Nuclear Medicine, the Hevesy Awards of both the European and the U.S. Society of Nuclear Medicine, Radiology Researcher of the Year (2004) and the Pendergrass Awards of the Radiologic Society of North America. He is a member of the Institute of Medicine of the National Academy of Sciences (NAS).
Cynthia Atkins-Duffin is an authority on physical and chemical behavior of actinide and fission product elements. She is the E Program Manager (Energy, Environment and Non-Proliferation) in the Global Security Directorate at Lawrence Livermore National Laboratory. Prior to this assignment she was the deputy associate director for strategic planning and resources in the Energy and Environment Directorate. Previously she has served as the Applied Energy Technologies program leader and the Yucca Mountain Program deputy program leader. In addition, she was deputy materials program leader in the Chemistry and Materials Science Directorate from 1999 to 2002, and deputy director of the Glenn T. Seaborg Institute for Trans-actinium Science from 1996 to 1999. Earlier she was principal investigator in the hydrology and radionuclide migration program within the nuclear weapons programs. Dr. Atkins-Duffin’s honors include the Chemistry and Materials Science Directorate Award (2001), the Energy Directorate Award (2000), and the American Institute of Chemists Award for Outstanding Undergraduate in Chemistry. She has authored or coauthored more than 40 refereed publications and given about 80 presentations. Dr. Atkins-Duffin received her Ph.D. in inorganic chemistry from Purdue University and her B.S. in chemistry from Worcester Polytechnic Institute.
Anthony Boardman is Van Dusen Professor of Business Administration in the Strategy and Business Economics Division at the University of British Columbia (UBC). His research interests include analysis of the effects of ownership on performance, privatization, public-private partnerships, cost-benefit and cost-effectiveness analyses, and strategic management in for-profit and nonprofit organizations. He is coauthor of a textbook, Cost-Benefit Analysis: Concepts and Practice. Dr. Boardman has extensive industry and consulting experience with a wide range of organizations in the private and public sectors. He has been a member of the Pharmacoeconomic Initiative